Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Amring Pharmaceuticals Inc

Amring Pharmaceuticals Inc Recalls

All product recalls associated with Amring Pharmaceuticals Inc.

Get alerts for this brand

Recall Summary

Total Recalls

1000

Past Year

304

Class I (Serious)

Most Recent

Nov 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 701–720 of 4747 recalls

Lysteda Tranexamic Acid Tablets (Amring) – Conductivity Specification (2023)

Failed Impurities/Degradation Specifications: Out of specification results obtained for conductivity.

Class IIILow

FDAJun 12, 2023Nationwide• Amring Pharmaceuticals Inc

Endometrin Vaginal Insert (Ferring) – Microbial Contamination Risk (2023)

cGMP deviations: potential for Microbial Contamination of Non-Sterile Products

Class IIModerate

FDAJun 12, 2023Nationwide• Ferring Pharmaceuticals Inc

Sterile Ultrasound Gel (Turkuaz) – Sterility Concern (2023)

Sterility of Ultrasound gel can not be guaranteed.

1...34 353637 38...238

Page 36 of 238Next

FDA

Jun 9, 2023

• Turkuaz Saglik Hizmetleri Medikal Temizlik Kim. Ur. San. ve Tic. A.S. Akcaburgaz Mahallesi Muhsin Yazicioglu Caddesi No:45/5 Esenyurt Turkey

VITROS Troponin I ES Reagent (ORTHO-CLINICAL) – Incorrect Wells (2023)

Reagent packs could potentially contain incorrect wells, which will generate incorrect, and potentially false negative, results.

FDAJun 5, 2023Nationwide• ORTHO-CLINICAL DIAGNOSTICS Felindre Meadows Bridgend United Kingdom

Epoc BGEM Crea Test Card (Siemens) – Glucose Result Discrepancy (2023)

There is potential for discrepant high glucose results in samples with glucose results on the lower end of the reportable range.

FDAJun 1, 2023AL, AZ, AR +23 more• Siemens Healthcare Diagnostics Inc

Epoc BGEM Veterinary Test Card (Siemens) – Glucose Result Discrepancy (2023)

There is potential for discrepant high glucose results in samples with glucose results on the lower end of the reportable range.

FDAJun 1, 2023AL, AZ, AR +23 more• Siemens Healthcare Diagnostics Inc

Epoc BGEM BUN Test Card (Siemens) – Glucose Result Discrepancy (2023)

There is potential for discrepant high glucose results in samples with glucose results on the lower end of the reportable range.

FDAJun 1, 2023AL, AZ, AR +23 more• Siemens Healthcare Diagnostics Inc

Trexo Device (Trexo Robotics) – Electrical Functionality Risks (2023)

Fire/Burn Risk

Electrical issues that could potentially render the device non-functional, give off electromagnetic influence to surrounding equipment, and risk of burns when in use.

FDAMay 31, 2023Nationwide• Trexo Robotics Holdings Inc.

Ziprasidone Hydrochloride Capsules (Harvard Drug Group) – Label Mix-up (2023)

Labeling: Label Mix-up: Unit Dose cartons labeled as Ziprasidone Hydrochloride Capsules, 20 mg were found to contain blister packages labeled as and containing Dronabinol Capsules, USP, 2.5 mg.

Class IHigh

FDAMay 31, 2023Nationwide• The Harvard Drug Group LLC dba Major Pharmaceuticals and Rugby Laboratories

Extended Phenytoin Sodium Capsules (Amneal) – Dissolution Failure (2023)

Failed Dissolution Specifications: Out-of-specification results for dissolution (above specification)

Class IIModerate

FDAMay 30, 2023LA, OH, PA• Amneal Pharmaceuticals of New York, LLC

Amphotericin B Liposome Injection (Sun Pharmaceutical) – Subpotent Drug (2023)

Subpotent drug

Class IIModerate

FDAMay 30, 2023Nationwide• SUN PHARMACEUTICAL INDUSTRIES INC

Nafcillin Injection 1g (Sagent) – Sterility Risk (2023)

Lack of Assurance of Sterility

Class IIModerate

FDAMay 19, 2023Nationwide• Sagent Pharmaceuticals Inc

Nafcillin Pharmacy Bulk Package (Sagent) – Sterility Risk (2023)

Lack of Assurance of Sterility

Class IIModerate

FDAMay 19, 2023Nationwide• Sagent Pharmaceuticals Inc

Nafcillin Injection 2g (Sagent) – Sterility Risk (2023)

Lack of Assurance of Sterility

Class IIModerate

FDAMay 19, 2023Nationwide• Sagent Pharmaceuticals Inc

VITROS NT-proBNP II (Ortho-Clinical) – Stability Specification (2023)

May not meet the stability specifications for shelf life outlined in the Instructions For Use (IFU).

FDAMay 18, 2023Nationwide• Ortho-Clinical Diagnostics, Inc.

Tico Spotter B 6.7 (Tico) – Steering Gear Problem (2023)

Terminal Investment Corporation (TICO) is recalling certain 2022-2023 Tico Spotter B 6.7 trucks equipped with certain Sheppard Steering Gears. The steering gear may have been assembled incorrectly, which can cause the gear to fracture.

NHTSAMay 18, 2023Nationwide• TICO

Aptio Automation SRM (Siemens) – Test Result Firmware Error (2023)

A firmware error may lead to an incorrect association of test result(s) to a sample ID and therefore to an incorrect patient result. The mis-association of test results, or a delay in testing, may occur when all the conditions listed below occur within a few milliseconds timeframe of each other: - The SRM module is releasing a sample tube (Tube A) just placed into the carrier - Another sample tube (Tube B) is erroneously not diverted into the SRM module buffer - There is divert gate malfunction and a narrow timing window Only in this specific scenario, Tube A may be released by the module as Tube B due to a miscommunication between the module firmware and the Automation software without a unique error message being generated. The Automation System loses the traceability of Tube A. It manages both Tube A (incorrectly identified as Tube B) and the real Tube B according to the pending test orders (not yet performed) on Tube B.

FDAMay 16, 2023Nationwide• Siemens Healthcare Diagnostics, Inc.

Foaming Hand Sanitizer (Alpha Aromatics) – Chemical Limit Exceeded (2023)

CGMP Deviations: FDA analysis found product to contain acetaldehyde and acetal above specification limits.

Class IIModerate

FDAMay 16, 2023IN, NC• Alpha Aromatics

Lorazepam Injection (Hikma) – Impurity Specification Failure (2023)

Failed Impurities/Degradation Specifications: Out-of-specification results for total related compounds observed during retain steting due to the elevated Related Compound-C.

Class IIModerate

FDAMay 11, 2023Nationwide• Hikma Pharmaceuticals USA Inc.

Bupropion Hydrochloride Tablets (Sun Pharma) – Failed Dissolution Test (2023)

Failed Dissolution Specifications; during stability testing

Class IIModerate

FDAMay 9, 2023Nationwide• SUN PHARMACEUTICAL INDUSTRIES INC